| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proteomics | 13 | 2024 | 476 | 1.260 |
Why?
|
| Proteome | 10 | 2024 | 233 | 1.140 |
Why?
|
| Protein Interaction Mapping | 6 | 2019 | 85 | 0.890 |
Why?
|
| Breast Neoplasms | 12 | 2024 | 2480 | 0.840 |
Why?
|
| Estrogen Receptor alpha | 7 | 2023 | 444 | 0.750 |
Why?
|
| Immunoprecipitation | 6 | 2019 | 198 | 0.610 |
Why?
|
| Mass Spectrometry | 7 | 2019 | 325 | 0.600 |
Why?
|
| Triple Negative Breast Neoplasms | 4 | 2023 | 217 | 0.550 |
Why?
|
| Infertility, Male | 3 | 2024 | 258 | 0.540 |
Why?
|
| Algorithms | 6 | 2020 | 1577 | 0.530 |
Why?
|
| Peptides | 2 | 2020 | 801 | 0.520 |
Why?
|
| Multiprotein Complexes | 4 | 2013 | 207 | 0.450 |
Why?
|
| CRISPR-Cas Systems | 3 | 2024 | 247 | 0.430 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 5 | 2015 | 392 | 0.390 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2020 | 1890 | 0.370 |
Why?
|
| Mice | 23 | 2025 | 17628 | 0.370 |
Why?
|
| Epithelial-Mesenchymal Transition | 2 | 2024 | 217 | 0.360 |
Why?
|
| HeLa Cells | 8 | 2019 | 808 | 0.350 |
Why?
|
| Proteins | 3 | 2023 | 1041 | 0.350 |
Why?
|
| Antineoplastic Agents | 3 | 2023 | 1679 | 0.350 |
Why?
|
| Transcriptional Activation | 3 | 2018 | 483 | 0.340 |
Why?
|
| Xenograft Model Antitumor Assays | 4 | 2025 | 873 | 0.340 |
Why?
|
| Animals | 30 | 2025 | 33888 | 0.340 |
Why?
|
| Proteogenomics | 3 | 2020 | 70 | 0.330 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2025 | 532 | 0.320 |
Why?
|
| Cell Line, Tumor | 11 | 2025 | 3299 | 0.320 |
Why?
|
| Cysteine Endopeptidases | 1 | 2009 | 115 | 0.320 |
Why?
|
| DNA Helicases | 2 | 2024 | 225 | 0.310 |
Why?
|
| Endometrial Neoplasms | 1 | 2009 | 99 | 0.300 |
Why?
|
| Tandem Mass Spectrometry | 6 | 2023 | 226 | 0.300 |
Why?
|
| Estrogens | 4 | 2023 | 505 | 0.240 |
Why?
|
| Fibrosis | 2 | 2024 | 429 | 0.240 |
Why?
|
| Response Elements | 3 | 2013 | 99 | 0.240 |
Why?
|
| Humans | 47 | 2025 | 122410 | 0.240 |
Why?
|
| CELF1 Protein | 1 | 2024 | 48 | 0.240 |
Why?
|
| Cyclic AMP Response Element Modulator | 1 | 2024 | 25 | 0.230 |
Why?
|
| Transcription Factors | 3 | 2024 | 2588 | 0.230 |
Why?
|
| Multigene Family | 1 | 2024 | 298 | 0.220 |
Why?
|
| Ribosomes | 2 | 2022 | 138 | 0.220 |
Why?
|
| Myeloproliferative Disorders | 1 | 2025 | 90 | 0.220 |
Why?
|
| Ubiquitination | 3 | 2024 | 173 | 0.220 |
Why?
|
| DNA | 3 | 2013 | 1606 | 0.220 |
Why?
|
| Peptide Hydrolases | 1 | 2023 | 139 | 0.200 |
Why?
|
| Prader-Willi Syndrome | 1 | 2023 | 67 | 0.200 |
Why?
|
| Host Cell Factor C1 | 1 | 2022 | 9 | 0.200 |
Why?
|
| Protein Binding | 7 | 2020 | 1736 | 0.200 |
Why?
|
| Homocystinuria | 1 | 2022 | 21 | 0.200 |
Why?
|
| Esomeprazole | 1 | 2022 | 31 | 0.200 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2022 | 39 | 0.190 |
Why?
|
| Oxidoreductases | 1 | 2022 | 92 | 0.190 |
Why?
|
| Heart Atria | 1 | 2024 | 308 | 0.190 |
Why?
|
| Host-Pathogen Interactions | 2 | 2015 | 252 | 0.190 |
Why?
|
| Nuclear Proteins | 3 | 2024 | 1282 | 0.190 |
Why?
|
| Mice, Transgenic | 2 | 2024 | 2441 | 0.190 |
Why?
|
| Genetic Techniques | 1 | 2021 | 102 | 0.190 |
Why?
|
| Repressor Proteins | 3 | 2022 | 814 | 0.180 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 2022 | 101 | 0.180 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2022 | 166 | 0.180 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2025 | 520 | 0.180 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2024 | 560 | 0.180 |
Why?
|
| Spliceosomes | 1 | 2021 | 48 | 0.180 |
Why?
|
| Unfolded Protein Response | 1 | 2020 | 62 | 0.180 |
Why?
|
| Aging | 2 | 2025 | 1164 | 0.180 |
Why?
|
| MCF-7 Cells | 5 | 2020 | 222 | 0.180 |
Why?
|
| Transcription, Genetic | 6 | 2020 | 1703 | 0.180 |
Why?
|
| Testis | 1 | 2022 | 401 | 0.180 |
Why?
|
| Carrier Proteins | 3 | 2023 | 1023 | 0.180 |
Why?
|
| Cleavage And Polyadenylation Specificity Factor | 1 | 2020 | 15 | 0.180 |
Why?
|
| RNA, Long Noncoding | 1 | 2023 | 210 | 0.180 |
Why?
|
| Chromatin | 3 | 2015 | 552 | 0.180 |
Why?
|
| Female | 24 | 2025 | 64958 | 0.170 |
Why?
|
| Stilbenes | 1 | 2020 | 34 | 0.170 |
Why?
|
| HIV-1 | 2 | 2015 | 464 | 0.170 |
Why?
|
| Hormones | 1 | 2020 | 189 | 0.170 |
Why?
|
| Immunity | 1 | 2021 | 184 | 0.170 |
Why?
|
| Estrogen Antagonists | 1 | 2020 | 103 | 0.170 |
Why?
|
| Polyadenylation | 1 | 2020 | 54 | 0.170 |
Why?
|
| RNA, Messenger | 4 | 2019 | 2833 | 0.170 |
Why?
|
| Trastuzumab | 1 | 2020 | 139 | 0.170 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2020 | 716 | 0.170 |
Why?
|
| Mice, Knockout | 6 | 2024 | 3776 | 0.160 |
Why?
|
| Protein Biosynthesis | 2 | 2022 | 668 | 0.160 |
Why?
|
| Claudins | 1 | 2018 | 29 | 0.160 |
Why?
|
| Trophoblasts | 1 | 2019 | 109 | 0.160 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 4 | 2015 | 551 | 0.160 |
Why?
|
| Molecular Targeted Therapy | 2 | 2021 | 354 | 0.160 |
Why?
|
| Eukaryotic Initiation Factor-4A | 1 | 2018 | 10 | 0.160 |
Why?
|
| Signal Transduction | 7 | 2021 | 4511 | 0.160 |
Why?
|
| NIH 3T3 Cells | 1 | 2018 | 92 | 0.160 |
Why?
|
| 3' Untranslated Regions | 1 | 2019 | 166 | 0.150 |
Why?
|
| Gene Expression Regulation | 6 | 2024 | 2541 | 0.150 |
Why?
|
| 5' Untranslated Regions | 1 | 2018 | 59 | 0.150 |
Why?
|
| Mitosis | 1 | 2018 | 239 | 0.150 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2018 | 66 | 0.150 |
Why?
|
| Genetic Markers | 1 | 2019 | 597 | 0.150 |
Why?
|
| Intestines | 1 | 2022 | 580 | 0.150 |
Why?
|
| Genes | 1 | 2018 | 443 | 0.140 |
Why?
|
| Cardiomyopathies | 1 | 2022 | 481 | 0.140 |
Why?
|
| Chromosome Disorders | 1 | 2019 | 310 | 0.140 |
Why?
|
| Reproducibility of Results | 3 | 2020 | 2794 | 0.140 |
Why?
|
| Pars Compacta | 1 | 2017 | 5 | 0.140 |
Why?
|
| Mice, SCID | 1 | 2018 | 572 | 0.140 |
Why?
|
| Apoptosis | 2 | 2021 | 1795 | 0.140 |
Why?
|
| Stem Cells | 1 | 2022 | 710 | 0.140 |
Why?
|
| Ventral Tegmental Area | 1 | 2017 | 50 | 0.140 |
Why?
|
| Wnt Signaling Pathway | 1 | 2018 | 200 | 0.140 |
Why?
|
| Atrial Fibrillation | 1 | 2024 | 622 | 0.140 |
Why?
|
| Drosophila | 1 | 2021 | 766 | 0.140 |
Why?
|
| Trans-Activators | 4 | 2013 | 805 | 0.140 |
Why?
|
| Receptor, ErbB-2 | 1 | 2020 | 496 | 0.130 |
Why?
|
| Immunity, Innate | 1 | 2019 | 375 | 0.130 |
Why?
|
| Shc Signaling Adaptor Proteins | 1 | 2015 | 12 | 0.130 |
Why?
|
| Estrogens, Conjugated (USP) | 1 | 2015 | 11 | 0.130 |
Why?
|
| Models, Biological | 3 | 2023 | 1439 | 0.130 |
Why?
|
| Muscle Proteins | 1 | 2018 | 416 | 0.130 |
Why?
|
| Placenta | 1 | 2019 | 490 | 0.130 |
Why?
|
| Cell Movement | 1 | 2018 | 839 | 0.120 |
Why?
|
| rev Gene Products, Human Immunodeficiency Virus | 1 | 2015 | 17 | 0.120 |
Why?
|
| Phosphorylation | 4 | 2024 | 1615 | 0.120 |
Why?
|
| Karyopherins | 1 | 2015 | 35 | 0.120 |
Why?
|
| RNA, Small Interfering | 2 | 2015 | 664 | 0.110 |
Why?
|
| Nuclear Receptor Coactivator 3 | 3 | 2013 | 346 | 0.110 |
Why?
|
| Nucleosomes | 1 | 2013 | 39 | 0.110 |
Why?
|
| Mice, Inbred C57BL | 5 | 2025 | 4385 | 0.110 |
Why?
|
| Male | 13 | 2025 | 59592 | 0.110 |
Why?
|
| Open Reading Frames | 2 | 2023 | 212 | 0.100 |
Why?
|
| tat Gene Products, Human Immunodeficiency Virus | 1 | 2012 | 31 | 0.100 |
Why?
|
| Cyclin T | 1 | 2012 | 34 | 0.100 |
Why?
|
| Spermatogenesis | 2 | 2024 | 163 | 0.100 |
Why?
|
| Protein Array Analysis | 1 | 2013 | 101 | 0.100 |
Why?
|
| Semen | 2 | 2023 | 71 | 0.100 |
Why?
|
| Cyclin-Dependent Kinase 9 | 1 | 2012 | 30 | 0.100 |
Why?
|
| Endometriosis | 1 | 2015 | 185 | 0.100 |
Why?
|
| Databases, Genetic | 1 | 2015 | 469 | 0.100 |
Why?
|
| MicroRNAs | 1 | 2019 | 837 | 0.100 |
Why?
|
| Spermatozoa | 2 | 2024 | 227 | 0.100 |
Why?
|
| Chromatography, Liquid | 3 | 2023 | 188 | 0.100 |
Why?
|
| Software | 2 | 2013 | 672 | 0.100 |
Why?
|
| Fertility | 2 | 2024 | 258 | 0.100 |
Why?
|
| Homeostasis | 1 | 2015 | 680 | 0.090 |
Why?
|
| Disease Models, Animal | 4 | 2024 | 4313 | 0.090 |
Why?
|
| Neoplasms | 2 | 2023 | 2751 | 0.090 |
Why?
|
| BRCA1 Protein | 1 | 2011 | 67 | 0.090 |
Why?
|
| Protein Structure, Tertiary | 2 | 2011 | 751 | 0.090 |
Why?
|
| Glucose | 1 | 2015 | 876 | 0.090 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2012 | 355 | 0.090 |
Why?
|
| Databases, Protein | 3 | 2020 | 55 | 0.090 |
Why?
|
| Amino Acid Sequence | 2 | 2012 | 2701 | 0.090 |
Why?
|
| Histone Deacetylase 2 | 1 | 2010 | 16 | 0.090 |
Why?
|
| Histone Deacetylase 1 | 1 | 2010 | 24 | 0.090 |
Why?
|
| Neurons | 1 | 2020 | 1924 | 0.090 |
Why?
|
| Oncogene Proteins | 2 | 2012 | 139 | 0.090 |
Why?
|
| Parkinson Disease | 1 | 2017 | 663 | 0.090 |
Why?
|
| Cardiovascular Diseases | 1 | 2022 | 1803 | 0.080 |
Why?
|
| Molecular Dynamics Simulation | 2 | 2020 | 103 | 0.080 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2011 | 215 | 0.080 |
Why?
|
| Deubiquitinating Enzymes | 1 | 2009 | 13 | 0.080 |
Why?
|
| Cell Line | 4 | 2019 | 2785 | 0.080 |
Why?
|
| Molecular Sequence Data | 2 | 2012 | 3887 | 0.080 |
Why?
|
| Solubility | 1 | 2009 | 133 | 0.080 |
Why?
|
| Alkaline Phosphatase | 1 | 2009 | 96 | 0.080 |
Why?
|
| Cell Proliferation | 3 | 2023 | 2315 | 0.080 |
Why?
|
| GPI-Linked Proteins | 1 | 2009 | 95 | 0.080 |
Why?
|
| Isoenzymes | 1 | 2009 | 223 | 0.080 |
Why?
|
| Liver | 2 | 2012 | 1858 | 0.080 |
Why?
|
| Cell Survival | 2 | 2020 | 817 | 0.080 |
Why?
|
| Biomarkers | 1 | 2017 | 2942 | 0.070 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2010 | 773 | 0.070 |
Why?
|
| Phenotype | 3 | 2023 | 4218 | 0.070 |
Why?
|
| Pyrimidines | 2 | 2025 | 374 | 0.070 |
Why?
|
| Cell Cycle Proteins | 1 | 2011 | 659 | 0.070 |
Why?
|
| Cell Nucleus | 1 | 2009 | 679 | 0.070 |
Why?
|
| Sex Factors | 2 | 2025 | 1236 | 0.070 |
Why?
|
| Acetyltransferases | 1 | 2006 | 91 | 0.060 |
Why?
|
| Ligands | 2 | 2020 | 534 | 0.060 |
Why?
|
| Autoantigens | 1 | 2006 | 132 | 0.060 |
Why?
|
| Proteinase Inhibitory Proteins, Secretory | 1 | 2024 | 6 | 0.060 |
Why?
|
| Ubiquitin | 1 | 2006 | 141 | 0.060 |
Why?
|
| Receptors, Progesterone | 1 | 2009 | 865 | 0.060 |
Why?
|
| DNA-Binding Proteins | 1 | 2013 | 2041 | 0.060 |
Why?
|
| Adenosine Triphosphate | 1 | 2006 | 288 | 0.060 |
Why?
|
| Transfection | 2 | 2019 | 1076 | 0.060 |
Why?
|
| DNA Copy Number Variations | 2 | 2020 | 943 | 0.060 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2006 | 279 | 0.060 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2017 | 339 | 0.060 |
Why?
|
| Acetylcysteine | 1 | 2025 | 74 | 0.060 |
Why?
|
| Sperm Motility | 1 | 2024 | 91 | 0.060 |
Why?
|
| Protein Stability | 1 | 2024 | 168 | 0.060 |
Why?
|
| Glycine | 1 | 2025 | 167 | 0.060 |
Why?
|
| Genome-Wide Association Study | 1 | 2011 | 1633 | 0.060 |
Why?
|
| Protein Kinase C | 1 | 2024 | 151 | 0.060 |
Why?
|
| Protein Interaction Maps | 1 | 2024 | 77 | 0.060 |
Why?
|
| Mutation | 3 | 2023 | 5786 | 0.060 |
Why?
|
| Glutathione | 1 | 2025 | 198 | 0.050 |
Why?
|
| Estradiol | 2 | 2020 | 534 | 0.050 |
Why?
|
| Purines | 1 | 2023 | 107 | 0.050 |
Why?
|
| Interferons | 1 | 2023 | 120 | 0.050 |
Why?
|
| Endopeptidases | 1 | 2023 | 114 | 0.050 |
Why?
|
| Extracellular Matrix | 1 | 2024 | 232 | 0.050 |
Why?
|
| Reproduction | 1 | 2024 | 237 | 0.050 |
Why?
|
| Zinc Finger Protein GLI1 | 1 | 2022 | 37 | 0.050 |
Why?
|
| Aminoimidazole Carboxamide | 1 | 2022 | 24 | 0.050 |
Why?
|
| Antioxidants | 1 | 2025 | 338 | 0.050 |
Why?
|
| Sterols | 1 | 2022 | 16 | 0.050 |
Why?
|
| Pyrazoles | 1 | 2025 | 301 | 0.050 |
Why?
|
| Amidohydrolases | 1 | 2022 | 18 | 0.050 |
Why?
|
| Organelle Biogenesis | 1 | 2022 | 16 | 0.050 |
Why?
|
| Acyl Coenzyme A | 1 | 2022 | 24 | 0.050 |
Why?
|
| Kidney | 1 | 2009 | 1345 | 0.050 |
Why?
|
| Neoplastic Stem Cells | 1 | 2024 | 295 | 0.050 |
Why?
|
| Vitamin B 12 | 1 | 2022 | 55 | 0.050 |
Why?
|
| Ribosomal Proteins | 1 | 2022 | 73 | 0.050 |
Why?
|
| Molecular Docking Simulation | 1 | 2022 | 113 | 0.050 |
Why?
|
| Cysteine | 1 | 2022 | 134 | 0.050 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2021 | 93 | 0.050 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2025 | 631 | 0.050 |
Why?
|
| Ganciclovir | 1 | 2021 | 105 | 0.050 |
Why?
|
| Receptors, Estrogen | 2 | 2020 | 788 | 0.050 |
Why?
|
| Gene Deletion | 1 | 2024 | 798 | 0.050 |
Why?
|
| Eye Proteins | 1 | 2022 | 217 | 0.050 |
Why?
|
| Protein Subunits | 1 | 2022 | 164 | 0.050 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2013 | 240 | 0.050 |
Why?
|
| Gentamicins | 1 | 2021 | 95 | 0.050 |
Why?
|
| Dietary Supplements | 1 | 2025 | 456 | 0.050 |
Why?
|
| Collagen | 1 | 2022 | 312 | 0.050 |
Why?
|
| Benzothiazoles | 1 | 2020 | 27 | 0.050 |
Why?
|
| Drug Resistance | 1 | 2021 | 257 | 0.050 |
Why?
|
| RNA, Double-Stranded | 1 | 2021 | 63 | 0.050 |
Why?
|
| X-Box Binding Protein 1 | 1 | 2020 | 29 | 0.050 |
Why?
|
| Fluorescence | 1 | 2020 | 93 | 0.050 |
Why?
|
| Animals, Genetically Modified | 1 | 2021 | 316 | 0.040 |
Why?
|
| HEK293 Cells | 2 | 2015 | 742 | 0.040 |
Why?
|
| Thermodynamics | 1 | 2020 | 141 | 0.040 |
Why?
|
| Transgenes | 1 | 2021 | 336 | 0.040 |
Why?
|
| Antigens, Neoplasm | 1 | 2023 | 394 | 0.040 |
Why?
|
| Gene Amplification | 1 | 2021 | 228 | 0.040 |
Why?
|
| Adaptive Immunity | 1 | 2021 | 89 | 0.040 |
Why?
|
| Endoribonucleases | 1 | 2020 | 84 | 0.040 |
Why?
|
| Tumor Microenvironment | 1 | 2023 | 547 | 0.040 |
Why?
|
| Introns | 1 | 2021 | 302 | 0.040 |
Why?
|
| Biopsy, Large-Core Needle | 1 | 2020 | 28 | 0.040 |
Why?
|
| Cytoplasm | 1 | 2021 | 290 | 0.040 |
Why?
|
| Epithelial Cells | 1 | 2024 | 907 | 0.040 |
Why?
|
| Heart | 1 | 2025 | 725 | 0.040 |
Why?
|
| DNA, Neoplasm | 1 | 2020 | 303 | 0.040 |
Why?
|
| Myocardium | 1 | 2025 | 983 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2021 | 187 | 0.040 |
Why?
|
| Embryo, Mammalian | 1 | 2022 | 453 | 0.040 |
Why?
|
| Protein Domains | 1 | 2020 | 233 | 0.040 |
Why?
|
| RNA Splicing | 1 | 2021 | 223 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2025 | 800 | 0.040 |
Why?
|
| Molecular Structure | 1 | 2020 | 284 | 0.040 |
Why?
|
| Proton Pump Inhibitors | 1 | 2022 | 253 | 0.040 |
Why?
|
| Cholesterol | 1 | 2022 | 507 | 0.040 |
Why?
|
| Computational Biology | 2 | 2015 | 793 | 0.040 |
Why?
|
| Zinc Finger E-box Binding Homeobox 2 | 1 | 2018 | 10 | 0.040 |
Why?
|
| Epidermal Growth Factor | 1 | 2019 | 122 | 0.040 |
Why?
|
| Snail Family Transcription Factors | 1 | 2018 | 24 | 0.040 |
Why?
|
| Workflow | 1 | 2019 | 114 | 0.040 |
Why?
|
| Zinc Finger E-box-Binding Homeobox 1 | 1 | 2018 | 25 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 2020 | 565 | 0.040 |
Why?
|
| Twist-Related Protein 1 | 1 | 2018 | 36 | 0.040 |
Why?
|
| Feedback, Physiological | 1 | 2018 | 69 | 0.040 |
Why?
|
| Gene Knockout Techniques | 1 | 2019 | 128 | 0.040 |
Why?
|
| Vimentin | 1 | 2018 | 65 | 0.040 |
Why?
|
| Triterpenes | 1 | 2018 | 21 | 0.040 |
Why?
|
| p21-Activated Kinases | 1 | 2018 | 59 | 0.040 |
Why?
|
| Protein Transport | 1 | 2019 | 369 | 0.040 |
Why?
|
| Heterografts | 1 | 2018 | 184 | 0.040 |
Why?
|
| ErbB Receptors | 1 | 2019 | 282 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2025 | 1250 | 0.040 |
Why?
|
| Diet | 1 | 2025 | 1091 | 0.040 |
Why?
|
| RNA Helicases | 1 | 2018 | 63 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2018 | 351 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2020 | 701 | 0.040 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2020 | 429 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2018 | 697 | 0.040 |
Why?
|
| False Negative Reactions | 1 | 2017 | 89 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2024 | 1674 | 0.040 |
Why?
|
| Single-Cell Analysis | 1 | 2019 | 260 | 0.040 |
Why?
|
| Homozygote | 1 | 2019 | 534 | 0.040 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2022 | 1007 | 0.030 |
Why?
|
| Nanotechnology | 1 | 2017 | 47 | 0.030 |
Why?
|
| False Positive Reactions | 1 | 2017 | 143 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2020 | 1069 | 0.030 |
Why?
|
| Heterozygote | 1 | 2019 | 681 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2017 | 309 | 0.030 |
Why?
|
| Rats | 1 | 2023 | 3660 | 0.030 |
Why?
|
| Translocation, Genetic | 1 | 2018 | 345 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2019 | 1005 | 0.030 |
Why?
|
| Glucokinase | 1 | 2015 | 16 | 0.030 |
Why?
|
| Reference Values | 1 | 2017 | 695 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2020 | 1364 | 0.030 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2015 | 60 | 0.030 |
Why?
|
| ROC Curve | 1 | 2017 | 552 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2022 | 1526 | 0.030 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2015 | 112 | 0.030 |
Why?
|
| Monitoring, Physiologic | 1 | 2017 | 355 | 0.030 |
Why?
|
| Brain Mapping | 1 | 2017 | 393 | 0.030 |
Why?
|
| Hippocampus | 1 | 2020 | 812 | 0.030 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2015 | 137 | 0.030 |
Why?
|
| Alleles | 1 | 2019 | 1594 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2020 | 3076 | 0.030 |
Why?
|
| Breast | 1 | 2015 | 214 | 0.030 |
Why?
|
| ATPases Associated with Diverse Cellular Activities | 1 | 2013 | 67 | 0.030 |
Why?
|
| Sialoglycoproteins | 1 | 2013 | 48 | 0.030 |
Why?
|
| DNA-Activated Protein Kinase | 1 | 2013 | 18 | 0.030 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2013 | 59 | 0.030 |
Why?
|
| Cyclopentanes | 1 | 2013 | 20 | 0.030 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2013 | 53 | 0.030 |
Why?
|
| Hep G2 Cells | 1 | 2013 | 92 | 0.030 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2013 | 95 | 0.030 |
Why?
|
| Biomarkers, Tumor | 1 | 2020 | 1431 | 0.030 |
Why?
|
| Endometrium | 1 | 2015 | 274 | 0.030 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2013 | 86 | 0.030 |
Why?
|
| Sin3 Histone Deacetylase and Corepressor Complex | 1 | 2012 | 5 | 0.030 |
Why?
|
| Protein Deglycase DJ-1 | 1 | 2012 | 12 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2013 | 386 | 0.030 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 1 | 1 | 2012 | 18 | 0.030 |
Why?
|
| RNA, Viral | 1 | 2015 | 540 | 0.030 |
Why?
|
| Carbohydrate Metabolism | 1 | 2012 | 54 | 0.030 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2012 | 135 | 0.020 |
Why?
|
| DNA Primers | 1 | 2013 | 669 | 0.020 |
Why?
|
| Protein Phosphatase 2 | 1 | 2011 | 29 | 0.020 |
Why?
|
| Molecular Conformation | 1 | 2011 | 95 | 0.020 |
Why?
|
| Nuclear Receptor Coactivators | 1 | 2012 | 72 | 0.020 |
Why?
|
| Histone Deacetylases | 1 | 2012 | 115 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2015 | 1000 | 0.020 |
Why?
|
| Virulence Factors | 1 | 2012 | 172 | 0.020 |
Why?
|
| Brain | 1 | 2023 | 2948 | 0.020 |
Why?
|
| Ubiquitinated Proteins | 1 | 2010 | 3 | 0.020 |
Why?
|
| Transcriptome | 1 | 2017 | 906 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2013 | 371 | 0.020 |
Why?
|
| Metabolic Diseases | 1 | 2012 | 129 | 0.020 |
Why?
|
| Molecular Weight | 1 | 2010 | 393 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2010 | 198 | 0.020 |
Why?
|
| Protein Kinases | 1 | 2011 | 330 | 0.020 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 1 | 2010 | 49 | 0.020 |
Why?
|
| RNA Polymerase II | 1 | 2010 | 99 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2013 | 1354 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2013 | 745 | 0.020 |
Why?
|
| Time Factors | 1 | 2019 | 6176 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2011 | 447 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2011 | 609 | 0.020 |
Why?
|
| RNA Interference | 1 | 2010 | 497 | 0.020 |
Why?
|
| Base Sequence | 1 | 2012 | 3118 | 0.020 |
Why?
|
| Risk Factors | 1 | 2022 | 9871 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2010 | 469 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2010 | 1106 | 0.020 |
Why?
|
| Binding Sites | 1 | 2010 | 1293 | 0.020 |
Why?
|
| Pregnancy | 1 | 2019 | 7102 | 0.020 |
Why?
|
| Cell Enlargement | 1 | 2006 | 9 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 1593 | 0.020 |
Why?
|
| Young Adult | 1 | 2019 | 8805 | 0.020 |
Why?
|
| Histone Acetyltransferases | 1 | 2006 | 313 | 0.020 |
Why?
|
| Cross Reactions | 1 | 2005 | 192 | 0.020 |
Why?
|
| Antibodies | 1 | 2005 | 371 | 0.010 |
Why?
|
| Genome, Human | 1 | 2010 | 1261 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2006 | 872 | 0.010 |
Why?
|
| Adult | 1 | 2019 | 28746 | 0.010 |
Why?
|